MarketInOut Stock Screener Log In | Sign Up

Advanced Biomed Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 11/02/2026 15:59
Advanced Biomed Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3.8 mln
Float0.95 mln
Earnings Date11/19/2026

Piotroski F-Score

6 / 9
Solid

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.09
Debt-free

Pre-Tax Margin

-4,922%
Severely loss-making

ROE

-99.51
Deeply negative

Altman Z-Score

63.45
Exceptional

Business Description

Advanced Biomed Inc. is a New York-based investment holding company, founded in 2014, that develops advanced microfluidic biochip technology aimed at detecting, diagnosing, and treating cancer with greater precision. The company produces a range of devices and diagnostic kits designed to identify and analyze rare cancer cells circulating in the blood, helping clinicians better understand a patient's tumor profile. It also provides related testing products and services directly to cancer patients, while working on new tools for early lung cancer screening. In addition, the company owns and runs medical clinics in China.

Key Fundamentals

EPS-5.00
ROE-99.51
RPS0.10
ROIC-63.80
ROA-56.59
Interest Cover-893
EBITDA, mln-0.20
EV / EBITDA-25.75
EV / EBIT-25.49
Revenue, mln0.00
EV / Revenue1,262

Quote Details

Last 2.08
Change -0.22 (-9.57%)
Open 2.45
Volume 9,764
Turnover 20,309
Average Volume 35,904

Financial Ratios

Pre-Tax Profit Margin-4,922
Leverage Ratio1.12
Current Ratio9.33
Price / Book13.05
Price / Tangible Book13.05
Debt / Equity0.09
Price / Sales1,520

Financial Strength

Altman Z-Score63.45
Piotroski F-Score 6 / 9
Short Ratio0.50
Short % of Float1.12

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -23.81% 3 / 100   
1 Month -69.09% 2 / 100   
2 Months -80.88% 2 / 100   
6 Months -65.1% 9 / 100   
1 Year -81.66% 9 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog